Tweet
Tn5
Does anyone know of another source of Tn5 transposase other than
FC 121 1030 form Illumina.
Cheers
FC 121 1030 form Illumina.
Cheers
-
-
Epicentre's EZ-Tn5 Transposase; TNP92110, which is a special order item. -
Thank you for the suggestion. Can Epicentre's EZ-Tn5 TNP92110 completely substitute for the Illumina product in terms of primer sequence, buffers, reaction conditions, etc.
Appreciated,
GenefuseComment
-
Happy to help - this is just the bare enzyme and users have to load any oligos themselves. Here's the product page link:
Reaction buffer and stop solution is provided; we don't do custom oligo loading.
Disclaimer: I am part of ILMN in Madison, WIComment
-
Great!
Much appreciated
GenefuseComment
-
Hi, gene fuse
Have you tried the EZ-Tn5 from epicenter? Could it be used for DNA library preparation?Comment
-
Tn5
Hi,
I have not had a chance to try EN-Tn5.
Olaf Blue might have more info on this
GenefuseComment
-
EZ-Tn5 from Epicentre has been transferred for sales and support to Lucigen:
OlafComment
-
I am finding the replacement of Nextera from Illumina but I am not sure if it could be used for tagmentation. It seems to be mostly used for the gene mutation.Comment
-
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has... -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM -
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...07-08-2026, 05:17 AM
Comment